Antiviral Agents

Encyclopedia of Virology

Volumn , Issue , 2008, Pages 142-154

  Field, H J ^a   Vere Hodge, R A ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Vere Hodge Antivirals Ltd   (United Kingdom)

Author keywords

Acyclovir; Antiviral chemotherapy; Antiviral drug resistance; Azidothymidine; CMV; Famciclovir; HBV; HCV; Herpesvirus; HIV; HSV; Influenza virus; Neuraminidase inhibitor; Non nucleoside reverse transcriptase inhibitor; Nucleoside analog; Ozeltamivir; Protease inhibitor; Reverse transcriptase inhibitor; Valaciclovir; Valganciclovir; VZV; Zanamivir

Indexed keywords

EID: 79951946883     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374410-4.00360-5     Document Type: Chapter

References (11)

1. Anderson R.M., May R.M. Infectious Diseasese of Humans Dynamics and Control 1992, Oxford University Press, New York.
2. De Clercq E. Recent highlights in the development of new antiviral drugs. Current Opinion in Microbiology 2005, 5:552-560.
3. De Clercq E. Antiviral drug discovery and development where chemistry meets with biomedicine. Antiviral Research 2005, 67:56-75.
4. De Clercq E., Branchale A., Vere Hodge A., Field H.J. Antiviral chemistry and chemotherapy's current antiviral agents FactFile 2006. Antiviral Chemistry and Chemotherapy 2006, 17:113-166. (1st edition).
5. De Clercq E., Field H.J. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. British Journal Pharmacology 2006, 147:1-11.
6. Field A.K., Loughlin C.A. Antivirals. Encyclopedia of Virology 1999, 54-68. Academic Press, New York. 2nd edn. A. Granoff, R.G. Webster (Eds.).
7. Field H.J., De Clercq E. Antiviral drugs: A short history of their discovery and development. Microbiology Today 2004, 31:58-61.
8. Field H.J., Whitley R.J. Antiviral chemotherapy. Topley and Wilson's Microbiology and Microbial Infections 2005, vol. 2:1605-1645. Hodder Arnold, London. 10th edn.
9. Schang L.M., Vincent M.R., Lacasse J.J. Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs. Antiviral Chemistry and Chemotherapy 2006, 17(6):293-320.
10. Wakita T., Pietschmann T., Kato T., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine 2005, 11(7):791-796.
11. Wutzler P., Thust R. Genetic risks of antiviral nucleoside analogues - a survey. Antiviral Research 2001, 49:55-74.